Our results are consistent with another report in which no mutations were detected in 60 breast cancer samples while three mutations were identified in 123 ovarian cancer samples [11], indicating that, although mutation of CHD5 could occur in breast cancer, its frequency is rather low in primary tumors. Here, CHD5 is linked to ovarian carcinoma.